Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Inactivation of Capicua drives cancer metastasis.

Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, Asthana S, Hrustanovic G, Flanagan J, Tulpule A, Blakely CM, Haringsma HJ, Simmons AD, Gowen K, Suh J, Miller VA, Ali S, Schuler M, Bivona TG.

Nat Genet. 2017 Jan;49(1):87-96. doi: 10.1038/ng.3728. Epub 2016 Nov 21.

2.

Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.

Simón-Carrasco L, Graña O, Salmón M, Jacob HKC, Gutierrez A, Jiménez G, Drosten M, Barbacid M.

Genes Dev. 2017 Jul 15;31(14):1456-1468. doi: 10.1101/gad.300244.117. Epub 2017 Aug 21.

3.

Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.

Kim E, Kim D, Lee JS, Yoe J, Park J, Kim CJ, Jeong D, Kim S, Lee Y.

Hepatology. 2018 Jun;67(6):2287-2301. doi: 10.1002/hep.29738. Epub 2018 Apr 19.

PMID:
29251790
4.

PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.

Avasarala S, Van Scoyk M, Karuppusamy Rathinam MK, Zerayesus S, Zhao X, Zhang W, Pergande MR, Borgia JA, DeGregori J, Port JD, Winn RA, Bikkavilli RK.

J Biol Chem. 2015 May 22;290(21):13479-89. doi: 10.1074/jbc.M114.636050. Epub 2015 Apr 6.

5.

Decreased TIP30 expression promotes tumor metastasis in lung cancer.

Tong X, Li K, Luo Z, Lu B, Liu X, Wang T, Pang M, Liang B, Tan M, Wu M, Zhao J, Guo Y.

Am J Pathol. 2009 May;174(5):1931-9. doi: 10.2353/ajpath.2009.080846. Epub 2009 Apr 6.

6.

ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.

Aytes A, Mitrofanova A, Kinkade CW, Lefebvre C, Lei M, Phelan V, LeKaye HC, Koutcher JA, Cardiff RD, Califano A, Shen MM, Abate-Shen C.

Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):E3506-15. doi: 10.1073/pnas.1303558110. Epub 2013 Aug 5.

7.

Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y, Wong MP.

PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.

8.

Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.

Hsu MK, Wu IC, Cheng CC, Su JL, Hsieh CH, Lin YS, Chen FC.

Oncotarget. 2015 Oct 6;6(30):28755-73. doi: 10.18632/oncotarget.4810.

9.

MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.

Shi L, Zhang B, Sun X, Lu S, Liu Z, Liu Y, Li H, Wang L, Wang X, Zhao C.

Br J Cancer. 2014 Dec 9;111(12):2316-27. doi: 10.1038/bjc.2014.580. Epub 2014 Nov 20.

10.

New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.

Bleau AM, Freire J, Pajares MJ, Zudaire I, Anton I, Nistal-Villán E, Redrado M, Zandueta CN, Garmendia I, Ajona D, Blanco D, Pio R, Lecanda F, Calvo A, Montuenga LM.

Int J Cancer. 2014 Dec 1;135(11):2516-27. doi: 10.1002/ijc.28574. Epub 2014 Jan 28.

11.

NANOG gene expression is regulated by the ETS transcription factor ETV4 in human embryonic carcinoma NCCIT cells.

Park SW, Do HJ, Choi W, Song H, Chung HJ, Kim JH.

Biochem Biophys Res Commun. 2017 Jun 3;487(3):532-538. doi: 10.1016/j.bbrc.2017.04.059. Epub 2017 Apr 13.

PMID:
28412366
12.

MiR-30c-2* negative regulated MTA-1 expression involved in metastasis and drug resistance of HPV-infected non-small cell lung cancer.

Wu YL, Hsu NY, Cheau-Feng Lin F, Lee H, Cheng YW.

Surgery. 2016 Dec;160(6):1591-1598. doi: 10.1016/j.surg.2016.06.025. Epub 2016 Aug 6.

PMID:
27506865
13.

Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.

Dat le T, Matsuo T, Yoshimaru T, Kakiuchi S, Goto H, Hanibuchi M, Kuramoto T, Nishioka Y, Sone S, Katagiri T.

Int J Oncol. 2012 May;40(5):1455-69. doi: 10.3892/ijo.2012.1348. Epub 2012 Jan 27.

PMID:
22294041
14.

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.

Mesquita D, Barros-Silva JD, Santos J, Skotheim RI, Lothe RA, Paulo P, Teixeira MR.

Oncotarget. 2015 Mar 10;6(7):5217-36.

15.

Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.

Modi S, Kubo A, Oie H, Coxon AB, Rehmatulla A, Kaye FJ.

Oncogene. 2000 Sep 21;19(40):4632-9.

16.

High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.

Chen P, Li K, Liang Y, Li L, Zhu X.

Exp Lung Res. 2013 Feb;39(1):9-17. doi: 10.3109/01902148.2012.744115. Epub 2012 Dec 5.

PMID:
23215946
17.

Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer.

Zhu X, Guo Y, Li X, Ding Y, Chen L.

J Thorac Oncol. 2010 Aug;5(8):1159-66. doi: 10.1097/JTO.0b013e3181e04d98.

18.

ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion.

Moss AC, Lawlor G, Murray D, Tighe D, Madden SF, Mulligan AM, Keane CO, Brady HR, Doran PP, MacMathuna P.

Biochem Biophys Res Commun. 2006 Jun 23;345(1):216-21. Epub 2006 Apr 27.

PMID:
16678123
19.

The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.

Jun HJ, Johnson H, Bronson RT, de Feraudy S, White F, Charest A.

Cancer Res. 2012 Aug 1;72(15):3764-74. doi: 10.1158/0008-5472.CAN-11-3990. Epub 2012 Jun 1.

20.

The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.

Yu J, Bulk E, Ji P, Hascher A, Tang M, Metzger R, Marra A, Serve H, Berdel WE, Wiewroth R, Koschmieder S, Müller-Tidow C.

Clin Cancer Res. 2010 Apr 15;16(8):2275-83. doi: 10.1158/1078-0432.CCR-09-2000. Epub 2010 Apr 6.

Supplemental Content

Support Center